Suppr超能文献

乌灵胶囊治疗脑卒中后抑郁的有效性和安全性:一项系统评价

Effectiveness and safety of Wuling capsule for post stroke depression: a systematic review.

作者信息

Peng Le, Zhang Xin, Kang De-Ying, Liu Xue-Ting, Hong Qi

机构信息

Department of Evidence-based Medicine and Clinical Epidemiology, West China Hospital, Sichuan University, Chengdu 610041, China.

Department of Evidence-based Medicine and Clinical Epidemiology, West China Hospital, Sichuan University, Chengdu 610041, China.

出版信息

Complement Ther Med. 2014 Jun;22(3):549-66. doi: 10.1016/j.ctim.2014.04.005. Epub 2014 May 6.

Abstract

OBJECTIVE

To review the effectiveness and safety of Wuling capsule for post stroke depression (PSD) systematically.

METHODS

We searched electronic databases for randomized controlled trials (RCTs) that compared either Wuling capsule with placebo, no treatment or Wuling capsule plus conventional treatment with conventional treatment alone in adults with post stroke depression. Relevant resources were also retrieved. Two reviewers screened the citations, assessed the risk of bias and extracted data independently.

RESULTS

A total of 16 studies involving 1378 patients were identified for this review. There were 3 trials comparing Wuling capsule with no treatment control and 13 trials comparing Wuling capsule plus conventional treatment (Deanxit, Fluoxetine, Sertraline, Paroxetine or Citalopram) with conventional treatment alone. Meta-analyses indicated Wuling capsule used alone or integrated with conventional treatment was effective for PSD in terms of HAMD (Hamilton depression scale) scores, response rate and with less adverse effects, of which, HAMD scores decreased significantly in favor of Wuling capsule from onset time to 1 week (SMD = 1.27, 95%CI: 0.71-1.83, P < 0.00001), 2 weeks (SMD = 1.45, 95%CI: 0.57-2.33, P = 0.001), 4 weeks (SMD = 2.84, 95%CI: 2.15-3.52, P < 0.00001), 6 weeks (SMD = 2.70, 95%CI: 2.15-3.24, P < 0.00001), and 8 weeks (SMD = 4.53, 95%CI: 3.55-5.50, P < 0.00001) and overall effect (SMD = 2.40, 95%CI: 1.75-3.05, P < 0.00001) (SMD = standardized mean difference).

CONCLUSION

Wuling capsule appeared to present certain antidepressant effect compared to no treatment control. With a combination of several Western medicines, Wuling capsule could be helpful in strengthening efficacy and reducing the incidence of adverse events as an alternative choice in the treatment of PSD. However, due to the limited number of included trials and relatively moderate methodological quality in the majority of studies, further large scale and rigorously designed trials are warranted to confirm the effectiveness and safety of Wuling capsule for post stroke depression.

摘要

目的

系统评价乌灵胶囊治疗脑卒中后抑郁(PSD)的有效性和安全性。

方法

检索电子数据库,查找比较乌灵胶囊与安慰剂、不治疗,或乌灵胶囊联合常规治疗与单纯常规治疗在成年脑卒中后抑郁患者中的随机对照试验(RCT)。还检索了相关资源。两名研究者独立筛选文献、评估偏倚风险并提取数据。

结果

本综述共纳入16项研究,涉及1378例患者。有3项试验比较乌灵胶囊与不治疗对照,13项试验比较乌灵胶囊联合常规治疗(黛力新、氟西汀、舍曲林、帕罗西汀或西酞普兰)与单纯常规治疗。Meta分析表明,单独使用乌灵胶囊或与常规治疗联合使用对PSD在汉密尔顿抑郁量表(HAMD)评分、有效率方面有效,且不良反应较少,其中,从开始至1周(标准化均数差值[SMD]=1.27,95%可信区间[CI]:0.71 - 1.83,P<0.00001)、2周(SMD = 1.45,95%CI:0.57 - 2.33,P = 0.001)、4周(SMD = 2.84,95%CI:2.15 - 3.52,P<0.00001)、6周(SMD = 2.70,95%CI:2.15 - 3.24,P<0.00001)和8周(SMD = 4.53,95%CI:3.55 - 5.50,P<0.00001)及总体效应(SMD = 2.40,95%CI:1.75 - 3.05,P<0.00001)时,HAMD评分显著降低,有利于乌灵胶囊(SMD=标准化均数差值)。

结论

与不治疗对照相比,乌灵胶囊似乎具有一定的抗抑郁作用。与几种西药联合使用时,乌灵胶囊作为PSD治疗的一种替代选择,可能有助于增强疗效并降低不良事件的发生率。然而,由于纳入试验数量有限且大多数研究的方法学质量相对一般,需要进一步开展大规模、设计严谨的试验来证实乌灵胶囊治疗脑卒中后抑郁的有效性和安全性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验